AgeX Therapeutics, Inc. (AGE)

NYSEAMERICAN: AGE · IEX Real-Time Price · USD
0.560
-0.010 (-1.82%)
Nov 29, 2022 3:59 PM EDT - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 202120202019201820172016
Revenue
0.140.361.731.41.41.67
Revenue Growth (YoY)
-60.11%-79.11%23.78%-0.57%-15.73%-
Cost of Revenue
0.020.030.240.360.170.3
Gross Profit
0.130.341.481.031.241.36
Selling, General & Admin
6.716.728.145.653.875.62
Research & Development
1.463.715.95.835.788.48
Other Operating Expenses
-0.55-0.1100.8-1.750
Operating Expenses
7.6110.3314.0412.287.914.1
Operating Income
-7.49-10-12.56-11.25-6.66-12.74
Interest Expense / Income
1.10.4-0.0300.010.03
Other Expense / Income
0.090.47-0.52-3.74-0.12.73
Pretax Income
-8.68-10.87-12.01-7.5-6.58-15.49
Income Tax
000.15000
Net Income
-8.68-10.87-12.15-7.5-6.58-15.49
Net Income Common
-8.68-10.87-12.15-7.5-6.58-15.49
Shares Outstanding (Basic)
383837353129
Shares Outstanding (Diluted)
383837353129
Shares Change
0.58%1.07%6.75%13.93%6.40%-
EPS (Basic)
-0.23-0.29-0.33-0.21-0.21-0.54
EPS (Diluted)
-0.23-0.29-0.33-0.21-0.21-0.54
Free Cash Flow Per Share
-0.21-0.21-0.29-0.23-0.20-0.29
Gross Margin
86.80%92.80%85.90%73.90%88.00%81.80%
Operating Margin
-5197.90%-2768.70%-726.80%-805.50%-474.60%-764.60%
Profit Margin
-6024.30%-3009.70%-703.40%-537.40%-468.70%-929.90%
Free Cash Flow Margin
-5454.90%-2170.90%-625.10%-574.20%-447.70%-507.20%
Effective Tax Rate
0.00%0.00%-1.23%0.00%0.00%0.00%
EBITDA
-7.45-9.21-11.08-6.97-5.89-14.62
EBITDA Margin
-5171.50%-2550.10%-641.40%-499.10%-419.20%-877.70%
Depreciation & Amortization
0.131.260.950.540.680.85
EBIT
-7.58-10.46-12.04-7.5-6.57-15.47
EBIT Margin
-5262.50%-2897.80%-696.50%-537.40%-467.80%-928.40%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).